These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24614357)

  • 1. Improvement in blood glucose control in patients with diabetes after implantation of left ventricular assist devices.
    Guglin M; Maguire K; Missimer T; Faber C; Caldeira C
    ASAIO J; 2014; 60(3):290-3. PubMed ID: 24614357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in glycemic control after left ventricular assist device implantation in advanced heart failure patients with diabetes mellitus.
    Choudhary N; Chen L; Kotyra L; Wittlin SD; Alexis JD
    ASAIO J; 2014; 60(6):675-80. PubMed ID: 25232763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Diabetes Mellitus on Outcomes in Patients Supported With Left Ventricular Assist Devices: A Single Institutional 9-Year Experience.
    Asleh R; Briasoulis A; Schettle SD; Tchantchaleishvili V; Pereira NL; Edwards BS; Clavell AL; Maltais S; Joyce DL; Joyce LD; Daly RC; Kushwaha SS; Stulak JM
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurohormonal regulation and improvement in blood glucose control: reduction of insulin requirement in patients with a nonpulsatile ventricular assist device.
    Koerner MM; El-Banayosy A; Eleuteri K; Kline C; Stephenson E; Pae W; Ghodsizad A
    Heart Surg Forum; 2014 Apr; 17(2):E98-102. PubMed ID: 24808450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantation of Left Ventricular Assist Device Results in Immediate Improvement of Glucose Metabolism in Patients With and Without Diabetes Mellitus.
    Goetz ME; Charnigo R; Guglin M
    Heart Lung Circ; 2020 Jun; 29(6):931-935. PubMed ID: 31235366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices.
    Uriel N; Naka Y; Colombo PC; Farr M; Pak SW; Cotarlan V; Albu JB; Gallagher D; Mancini D; Ginsberg HN; Jorde UP
    Eur J Heart Fail; 2011 Feb; 13(2):195-9. PubMed ID: 21098576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Diabetes Mellitus a Risk Factor for Poor Outcomes after Left Ventricular Assist Device Placement?
    Mohamedali B; Yost G; Bhat G
    Tex Heart Inst J; 2017 Apr; 44(2):115-119. PubMed ID: 28461796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive Impact of Continuous-Flow Left Ventricular Assist Device Implantation on Glycemic Control in Patients with Type 2 Diabetes Mellitus and Advanced Chronic Systolic Heart Failure.
    Yen DC; Watson MH; Burgess LD; Kuchibhatla M; Patel CB; Campbell KB; Vora AK
    Pharmacotherapy; 2016 Dec; 36(12):1210-1216. PubMed ID: 27779786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanical circulatory support improves diabetic control in patients with advanced heart failure.
    Mohamedali B; Yost G; Bhat G
    Eur J Heart Fail; 2014 Oct; 16(10):1120-4. PubMed ID: 25298334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular assist device implantation improves glycaemic control: a systematic review and meta-analysis.
    Patel N; Gluck JA; Radojevic J; Coleman CI; Baker WL
    ESC Heart Fail; 2018 Dec; 5(6):1141-1149. PubMed ID: 30052326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of left ventricular assist device on diabetes management: an evaluation through case analysis and clinical impact.
    Subauste AR; Esfandiari NH; Qu Y; Oral EA; Aaronson KD; Pagani FD; Gianchandani RG
    Hosp Pract (1995); 2014 Aug; 42(3):116-22. PubMed ID: 25255413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Dysfunction in Continuous-Flow Left Ventricular Assist Devices Patients and Outcomes.
    Nguyen AB; Imamura T; Besser S; Rodgers D; Chung B; Raikhelkar J; Kalantari S; Smith B; Sarswat N; LaBuhn C; Jeevanandam V; Kim G; Sayer G; Uriel N
    J Am Heart Assoc; 2019 Nov; 8(22):e013278. PubMed ID: 31718441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes for Patients With Diabetes After Continuous-Flow Left Ventricular Assist Device Implantation.
    Vest AR; Mistak SM; Hachamovitch R; Mountis MM; Moazami N; Young JB
    J Card Fail; 2016 Oct; 22(10):789-96. PubMed ID: 26924520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairments in Blood Pressure Regulation and Cardiac Baroreceptor Sensitivity Among Patients With Heart Failure Supported With Continuous-Flow Left Ventricular Assist Devices.
    Sailer C; Edelmann H; Buchanan C; Giro P; Babcock M; Swanson C; Spotts M; Schulte M; Pratt-Cordova A; Coe G; Beindorff M; Page RL; Ambardekar AV; Pal JD; Kohrt W; Wolfel E; Lawley JS; Tarumi T; Cornwell WK
    Circ Heart Fail; 2021 Jan; 14(1):e007448. PubMed ID: 33464953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Impact of Diabetes Mellitus on Short-Term Outcomes andIn-Hospital Mortality of Cardiac Mechanical Support with Left Ventricular Assist Device (LVAD): A Retrospective Study from a National Database.
    Yassin AS; Subahi A; Adegbala O; Abubakar H; Akintoye E; Ahmed A; Ismail A; Elhag A; Kambal A; Alade A; Shokr M; Weinberger J; Levine D; Afonso L
    Cardiovasc Revasc Med; 2019 Oct; 20(10):883-886. PubMed ID: 30578171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Neurohormonal Blockade Drug Therapy on Outcomes and Left Ventricular Function and Structure After Left Ventricular Assist Device Implantation.
    Grupper A; Zhao YM; Sajgalik P; Joyce LD; Park SJ; Pereira NL; Stulak JM; Burnett JC; Edwards BS; Daly RC; Kushwaha SS; Schirger JA
    Am J Cardiol; 2016 Jun; 117(11):1765-70. PubMed ID: 27079215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in pulmonary artery pressure before and after left ventricular assist device implantation in patients utilizing remote haemodynamic monitoring.
    Kilic A; Katz JN; Joseph SM; Brisco-Bacik MA; Uriel N; Lima B; Agarwal R; Bharmi R; Farrar DJ; Lee S;
    ESC Heart Fail; 2019 Feb; 6(1):138-145. PubMed ID: 30350926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slope of the anterior mitral valve leaflet: a new measurement of left ventricular unloading for left ventricular assist devices and systolic dysfunction.
    Martinez SC; Bradley EA; Novak EL; Rasalingam R; Cedars AM; Ewald GA; Silvestry SC; Joseph SM
    Tex Heart Inst J; 2014 Jun; 41(3):262-72. PubMed ID: 24955040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous flow left ventricular assist device implant significantly improves pulmonary hypertension, right ventricular contractility, and tricuspid valve competence.
    Atluri P; Fairman AS; MacArthur JW; Goldstone AB; Cohen JE; Howard JL; Zalewski CM; Shudo Y; Woo YJ
    J Card Surg; 2013 Nov; 28(6):770-5. PubMed ID: 24118109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.